Inhibitor potency and assay conditions: A case study on SARS-CoV-2 main protease

Proc Natl Acad Sci U S A. 2021 Sep 7;118(36):e2106095118. doi: 10.1073/pnas.2106095118.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Humans
  • Molecular Docking Simulation
  • Peptide Hydrolases
  • Protease Inhibitors
  • SARS-CoV-2*

Substances

  • Protease Inhibitors
  • Peptide Hydrolases